Wasatch Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Wasatch Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,437,960	Closed	-$5.75M	–	234
2026 Q1	$5.75M	Buy	+1,437,960	New	+$7.04M	0.04%	155

Other funds holding TLSI

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

RDFA

Ritter Daniher Financial Advisory Cincinnati, Ohio $657M AUM 20.27% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Wasatch Advisors's TLSI Position: Q2 2026 in Review

Wasatch Advisors sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 1,437,960 shares — an estimated $5.75M sold.

Wasatch Advisors first reported a position in TLSI in Q1 2026 and held it in 1 quarter. The position peaked at $5.75M in Q1 2026. 4 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Wasatch Advisors reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
Wasatch Advisors sold 1,437,960 TriSalus Life Sciences shares in Q2 2026, an estimated $5.75M.
Wasatch Advisors first reported a position in TriSalus Life Sciences in Q1 2026 and held it in 1 quarter.
Wasatch Advisors's TriSalus Life Sciences position peaked at $5.75M in Q1 2026.
4 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.